Life-saving drug for cystic fibrosis inaccessible for most
About 4,200 Canadians have cystic fibrosis. There are three gene-modifying drugs available — Symdeko, Kalydeco and Orkambi — that are believed to slow down lung damage caused by the disease. Access to all three medications is severely limited.
2:32
30:06
6:30
22:51
9:17
4:55
1:48
1:59
2:08
2:11
